Literature DB >> 14493458

Circulatory and respiratory effects of guanethidin.

R ROKSETH, O STORSTEIN, A VOLL, A M ABRAHAMSEN, J OFSTAD.   

Abstract

Entities:  

Keywords:  AMIDINES/therapy; HYPERTENSION, PULMONARY/therapy; RESPIRATION/pharmacology

Mesh:

Substances:

Year:  1962        PMID: 14493458      PMCID: PMC1017868          DOI: 10.1136/hrt.24.2.195

Source DB:  PubMed          Journal:  Br Heart J        ISSN: 0007-0769


× No keyword cloud information.
  11 in total

1.  Some pharmacological actions of bretylium and guanethidine.

Authors:  J VERNIKOS-DANELLIS; E ZAIMIS
Journal:  Lancet       Date:  1960-10-08       Impact factor: 79.321

2.  The circul atory effects of bretylium tosylate and guanethidine.

Authors:  S H TAYLOR; K W DONALD
Journal:  Lancet       Date:  1960-08-20       Impact factor: 79.321

3.  Pharmacology of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (Su-5864).

Authors:  R A MAXWELL; A J PLUMMER; F SCHNEIDER; H POVALSKI; A I DANIEL
Journal:  J Pharmacol Exp Ther       Date:  1960-01       Impact factor: 4.030

4.  Muscle weakness caused by bretylium tosylate.

Authors:  E D CAMPBELL; E MONTUSCHI
Journal:  Lancet       Date:  1960-10-08       Impact factor: 79.321

5.  Effect of guanethidine and bretylium on the dog heart-lung preparation.

Authors:  T E GAFFNEY
Journal:  Circ Res       Date:  1961-01       Impact factor: 17.367

6.  A new, potent antihypertensive drug: preliminary study of [2-(octahydro-1-azocinyl)-ethyl]-guanidine sulfate (guanethidine).

Authors:  I H PAGE; H P DUSTAN
Journal:  J Am Med Assoc       Date:  1959-07-11

7.  [Clinical and experimental studies on the hypotensive effect of guanethidine].

Authors:  P LICHTLEN; F SCHAUB; A BUEHLMANN
Journal:  Dtsch Med Wochenschr       Date:  1960-07-09       Impact factor: 0.628

8.  Guanethidine; hypotensive drug with prolonged action.

Authors:  A W LEISHMAN; H L MATTHEWS; A J SMITH
Journal:  Lancet       Date:  1959-12-12       Impact factor: 79.321

9.  Spectrophotometric studies. XVI. Determination of the oxygen saturation of blood by a simplified technique, applicable to standard equipment.

Authors:  E GORDY; D L DRABKIN
Journal:  J Biol Chem       Date:  1957-07       Impact factor: 5.157

10.  [2-Octahydro-1-azocinyl)-ethyl]-guanidine sulfate (CIBA 5864-SU), a new synthetic antithypertensive agents].

Authors:  R A MAXWELL; R P MULL; A J PLUMMER
Journal:  Experientia       Date:  1959-07-15
View more
  1 in total

1.  GUANETHIDINE AND METHYLDOPA: A HAEMODYNAMIC STUDY.

Authors:  D A CHAMBERLAIN; J HOWARD
Journal:  Br Heart J       Date:  1964-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.